Dong Sung Bio Pharm.Co.,Ltd. (KRX:002210)
South Korea · Delayed Price · Currency is KRW 973.00
-1,807.00 (-65.00%)
At close: Jun 24, 2025
KRX:002210 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|
Period Ending | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 |
Net Income | 1,701 | -7,855 | 568.43 | 3,657 | 2,656 |
Depreciation & Amortization | 1,507 | 1,510 | 1,316 | 1,386 | 1,465 |
Other Amortization | - | - | - | - | 0.3 |
Loss (Gain) From Sale of Assets | 7.31 | -7.81 | -3.23 | -4,557 | -3,811 |
Asset Writedown & Restructuring Costs | - | - | - | 175.52 | - |
Loss (Gain) From Sale of Investments | 6.26 | -102.22 | -59.3 | 805.14 | 762.62 |
Provision & Write-off of Bad Debts | 2,987 | 3,365 | 738.6 | 573.78 | 1,909 |
Other Operating Activities | -1,803 | 4,861 | 2,315 | 3,485 | 2,463 |
Change in Accounts Receivable | -3,518 | -1,016 | -4,073 | -1,442 | -323.42 |
Change in Inventory | -621.62 | 1,523 | -1,782 | -274.32 | -676.38 |
Change in Accounts Payable | 231.65 | 2,644 | -255.05 | 132.42 | -1,062 |
Change in Income Taxes | - | - | -519.8 | -754.77 | 582.72 |
Change in Other Net Operating Assets | -3,141 | -1,237 | -2,987 | -4,160 | -1,040 |
Operating Cash Flow | -2,643 | 3,685 | -5,021 | -365.26 | 2,917 |
Operating Cash Flow Growth | - | - | - | - | -16.85% |
Capital Expenditures | -380.7 | -847.33 | -721.58 | -417.02 | -1,715 |
Sale of Property, Plant & Equipment | 10 | 8.11 | 7.18 | 550 | 272.02 |
Sale (Purchase) of Intangibles | -447.91 | -99.72 | -222.93 | -679.7 | -32.43 |
Sale (Purchase) of Real Estate | - | - | -5 | 7,050 | 3,190 |
Investment in Securities | 4,902 | 213.16 | -405.86 | -708.76 | -9,774 |
Other Investing Activities | 529.49 | 483.47 | 693.41 | -303.98 | -74.3 |
Investing Cash Flow | 3,403 | -402.23 | -1,444 | 5,239 | -7,951 |
Short-Term Debt Issued | 14,005 | 16,380 | 10,500 | - | - |
Long-Term Debt Issued | - | 2,000 | 1,160 | - | 12,470 |
Total Debt Issued | 14,005 | 18,380 | 11,660 | - | 12,470 |
Short-Term Debt Repaid | -12,081 | -9,800 | -6,900 | -3,700 | - |
Long-Term Debt Repaid | -869 | -6,247 | -337.74 | -925.24 | -12,274 |
Total Debt Repaid | -12,950 | -16,047 | -7,238 | -4,625 | -12,274 |
Net Debt Issued (Repaid) | 1,055 | 2,334 | 4,422 | -4,625 | 195.7 |
Issuance of Common Stock | - | - | - | - | 2,784 |
Repurchase of Common Stock | - | -899.28 | - | - | - |
Common Dividends Paid | - | - | -544.74 | -544.74 | -685.49 |
Dividends Paid | -529.74 | -544.74 | -544.74 | -544.74 | -685.49 |
Other Financing Activities | -670.87 | 297.87 | 271 | -225.61 | -53 |
Financing Cash Flow | -145.4 | 1,187 | 4,149 | -5,396 | 2,242 |
Foreign Exchange Rate Adjustments | 138.39 | 74.06 | - | - | - |
Miscellaneous Cash Flow Adjustments | 0 | -74.06 | - | - | - |
Net Cash Flow | 752.68 | 4,470 | -2,317 | -522.03 | -2,792 |
Free Cash Flow | -3,024 | 2,837 | -5,743 | -782.29 | 1,202 |
Free Cash Flow Growth | - | - | - | - | -51.90% |
Free Cash Flow Margin | -3.85% | 3.94% | -8.36% | -1.26% | 1.99% |
Free Cash Flow Per Share | -171.26 | 157.50 | -316.25 | -43.08 | 69.11 |
Cash Interest Paid | 1,791 | 2,078 | - | - | - |
Cash Income Tax Paid | 4,145 | -211.45 | - | - | - |
Levered Free Cash Flow | -5,054 | 9,644 | -6,165 | -694.99 | 726.73 |
Unlevered Free Cash Flow | -3,802 | 11,079 | -5,102 | 447.79 | 1,955 |
Change in Working Capital | -7,049 | 1,914 | -9,896 | -5,891 | -2,528 |
Updated Aug 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.